Navigation Links
RAPS Partners With Chinese University to Develop Regulatory Courses

RAPS to Collaborate With University of Shanghai for Science and Technology to Provide Course Content and Develop Curricula on Healthcare Products Regulation.

Rockville, MD, USA (Vocus) May 4, 2010 —The Regulatory Affairs Professionals Society (RAPS) this week announced an agreement with the University of Shanghai for Science and Technology (USST) in Shanghai, China, to work collaboratively in developing regulatory education content for the university. As part of the agreement, RAPS will provide some of its existing online course content currently offered through RAPS Online University, which will be adapted for USST’s students, as well as guide the university in developing new regulatory curricula and providing advice and support to university faculty. The partnership will initially focus on courses covering regulation of medical devices, but could possibly expand to cover pharmaceutical or other medical products in the future.

“USST is the only school in China offering bachelor’s, master’s and PhD programs in medical devices and is in an important position for educating and training regulatory professionals in China and internationally,” said Dr. Baolin Liu, Professor and Dean, School of Medical Instrument and Food Engineering, USST, Shanghai. “We had hoped to partner with RAPS, the leading international regulatory professional organization, and look forward to great success.”

The healthcare sector in China is developing rapidly and the need for comprehensive regulatory knowledge is on the rise among researchers, scientists, engineers, business professionals, government officials and others. The regulatory coursework offered through the RAPS-USST collaboration will be aimed at three primary audiences: potential and new regulatory professionals, scientists and engineers involved in medical technology research and development and government inspectors.

“This partnership represents an important step forward for the global regulatory profession and further demonstrates the profession’s critical importance in the continued global expansion of the healthcare products sector,” said RAPS Chairman Mark Gordon. “RAPS is glad to be in a position to help connect regulatory professionals in emerging healthcare markets like China with the collective expertise of the worldwide regulatory community.”

About RAPS
The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Private Sector Investment in Agriculture Emerging as a Significant Alternative Asset Class: New HighQuest Partners Study
2. Sidus BioData Partners with Life Science Software Provider RuRo
3. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
4. ClearTrial Unveils New Product Release at Partnerships in Clinical Trials Conference 2010
5. NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference
6. Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16
7. Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast
8. LifeNet Health and Soluble Systems Announce Partnership to Launch TheraSkin(TM)
9. INC Research and invivodata Announce ePRO Partnership
10. Atacama Labs Enters Into Partnership With Excella Gmbh, Which is Part of Fareva Holding, a Top 10 Global Contract Manufacturer
11. PDI to Present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference
Post Your Comments:
Related Image:
RAPS Partners With Chinese University to Develop Regulatory Courses
(Date:11/27/2015)... 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), ... has closed the sale of its global contrast media ... Euronext) in a transaction valued at approximately $270 million. ... a total of approximately 1,000 employees spread across the ... Louis area. This entire workforce and the ...
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
Breaking Biology Technology:
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):